DCF — DEBORAH HEART AND LUNG CENTER
Enterprise Value: $-201.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-201.7M
Enterprise Value
$-66.9M
PV of Cash Flows
$-134.8M
PV of Terminal Value
$-217.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $218.3M | $-10.9M | -5.0% | $-20.1M | $-18.3M |
| Year 2 | $224.8M | $-8.9M | -4.0% | $-18.5M | $-15.3M |
| Year 3 | $231.6M | $-6.9M | -3.0% | $-16.7M | $-12.6M |
| Year 4 | $238.5M | $-5.9M | -2.0% | $-16.0M | $-10.9M |
| Year 5 | $245.7M | $-5.5M | -2.0% | $-15.9M | $-9.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-201.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$211.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.054803355270624035
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5